Home › Funds › Nantahala Capital Management, LLC › LBRX

Nantahala Capital Management, LLC position in LBRX

LB PHARMACEUTICALS INC · Health Care

Nantahala Capital Management, LLC reported holding 1,074,374 shares of LBRX (LB PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$41.2M, representing 1.89% of its reported portfolio and ranking #10 among its reported holdings. Nantahala Capital Management, LLC has disclosed LBRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)1.07M sh
Reported value held$41.23M
Portfolio Weight1.89%
First reportedQ3 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nantahala Capital Management, LLC's LBRX position evolved

Nantahala Capital Management, LLC first disclosed a stake in LBRX in Q3 2025 at 675,000 shares (US$10.7M). The position peaked in Q3 2026 at 1,074,374 shares, worth US$41.2M. Across 5 filings, Nantahala Capital Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,074,374 shares valued at US$41.2M — an increase of 21,480 shares quarter over quarter.. Notable position changes include a 56% increase in Q1 2026 (shares rose 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 675.00K $10.66M New
Q4 2025 675.00K $15.03M Hold
Q1 2026 1.05M $25.96M Add
Q2 2026 1.05M $34.17M Hold
Q3 2026 1.07M $41.23M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LBRX and 13F data

LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 106 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$108.8M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Spruce Street Capital LP (US$53.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LBRX

All LBRX fund holders →

FAQ

How long has Nantahala Capital Management, LLC held LBRX?

Nantahala Capital Management, LLC has disclosed LBRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Nantahala Capital Management, LLC's current position in LBRX?

As of Q3 2026, Nantahala Capital Management, LLC holds 1.07M shares of LBRX (LB PHARMACEUTICALS INC), valued at $41.23M, representing 1.89% of its reported portfolio and ranking #10.

Has Nantahala Capital Management, LLC been buying or selling LBRX?

In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC increased its position in LBRX. The position peaked in Q3 2026 at 1.07M shares.

Which other funds hold LBRX?

Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Spruce Street Capital LP, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.